Literature DB >> 3308740

The importance of surveillance stool cultures during periods of severe neutropenia.

C L Wells1, P Ferrieri, D J Weisdorf, F S Rhame.   

Abstract

The correlation of fecal gram-negative bacilli (GNB), neutropenia, and bacteremia was studied in 45 bone marrow transplant recipients. Weekly stool cultures were prospectively monitored for GNB resistant to routine prophylactic and empiric antimicrobial agents. Seven cases of GNB bacteremia occurred in 45 patients described as follows. Twenty-three patients had no fecal or blood GNB. Fifteen patients had fecal GNB and no blood GNB; three of these latter patients had less than or equal to 50/mm3 circulating white blood cells (WBC) at the time of isolation of fecal GNB but two of the three were concurrently receiving appropriate empiric antibiotics. Two patients had blood GNB but no fecal GNB: one patient had a trimethoprim/sulfamethoxazole (TMP-SMZ)-sensitive isolate that would not be detectable in the feces by our methodology and one patient had feces analyzed only after the bacteremic event. Five patients had fecal GNB and blood GNB: one of these patients did not have a fecal sample analyzed prior to bacteremia but the remaining four patients had the same species/antibiogram of GNB isolated from the feces two to three days prior to the detection of bacteremia. Thus, the fecal GNB could have been used to predict the antibiogram of the subsequent blood GNB. In addition, all four of these latter bacteremic patients had less than or equal to 50/mm3 circulating WBC at the time of documented fecal GNB. Thus, bone marrow transplant recipients with fecal GNB coupled with severe neutropenia (less than or equal to 50/mm3 circulating WBC) were more likely to develop bacteremia (P less than 0.02) than were those with fecal GNB and greater than 50/mm3 circulating WBC.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3308740     DOI: 10.1017/s0195941700066406

Source DB:  PubMed          Journal:  Infect Control        ISSN: 0195-9417


  6 in total

1.  Ability of intestinal Escherichia coli to survive within mesenteric lymph nodes.

Authors:  C L Wells; M A Maddaus; R P Jechorek; R L Simmons
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

2.  Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia.

Authors:  Ryoko Yamasaki; Junya Kanda; Yu Akahoshi; Hirofumi Nakano; Tomotaka Ugai; Hidenori Wada; Koji Kawamura; Yuko Ishihara; Kana Sakamoto; Miki Sato; Masahiro Ashizawa; Tomohito Machishima; Kiriko Terasako-Saito; Shun-Ichi Kimura; Misato Kikuchi; Hideki Nakasone; Rie Yamazaki; Shinichi Kako; Junji Nishida; Yoshinobu Kanda
Journal:  Int J Hematol       Date:  2017-02-06       Impact factor: 2.490

3.  Prevention of indigenous infection of mice with Escherichia coli by nonspecific immunostimulation.

Authors:  K Nomoto; T Yokokura; M Mitsuyama; Y Yoshikai; K Nomoto
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

4.  Prior colonization is associated with increased risk of antibiotic-resistant Gram-negative bacteremia in cancer patients.

Authors:  Aaron S Hess; Michael Kleinberg; John D Sorkin; Giora Netzer; Jennifer K Johnson; Michelle Shardell; Kerri A Thom; Anthony D Harris; Mary-Claire Roghmann
Journal:  Diagn Microbiol Infect Dis       Date:  2014-01-30       Impact factor: 2.803

5.  Antibacterial effect of bovine milk antibody against Escherichia coli in a mouse indigenous infection model.

Authors:  K Nomoto; Y Matsuoka; K Hayakawa; M Ohwaki; T Kan; Y Yoshikai; K Nomoto
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

6.  Value of surveillance cultures in the management of neutropenic patients.

Authors:  M A Daw; P Munnelly; S R McCann; P A Daly; F R Falkiner; C T Keane
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.